Radiopharm Theranostics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions AUD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Radiopharm Theranostics Limited (RADX) - Annual data in millions AUD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun 2025Dec 2024Jun 2023Jun 2022Jun 2021
Operating Activities
Net Income-38.340.00-34.61-30.42-1.16
Depreciation & Amortization2.600.003.302.980.00
Stock Based Compensation1.900.003.044.800.86
Change in Working Capital-5.950.003.952.250.22
Change in Accounts Receivable-9.410.001.51-0.05-0.02
Change in Accounts Payable0.510.002.352.530.24
Change in Other Working Capital2.950.000.10-0.230.00
Other Operating Activities3.16-36.651.1310.480.00
Net Cash from Operating Activities-36.65-36.65-23.20-9.91-0.08
Investing Activities
Capital Expenditures0.000.00-1.530.000.00
Purchases of Investments0.000.000.00-0.040.00
Sales/Maturities of Investments3.000.00-1.49-28.340.00
Other Investing Activities-1.231.770.000.000.00
Net Cash from Investing Activities1.771.77-1.53-28.380.00
Financing Activities
Debt Repayment-1.90-1.900.00-0.070.00
Common Stock Issued53.9853.9810.0770.000.00
Common Stock Repurchased0.000.00-0.85-4.830.00
Other Financing Activities-6.65-6.65-0.85-4.830.00
Net Cash from Financing Activities45.4345.439.2265.110.14
Summary
Effect of Forex Changes on Cash-0.01-0.010.230.130.00
Net Change in Cash10.5610.54-15.5126.950.07
Cash at Beginning of Period18.5818.5826.980.030.00
Cash at End of Period29.1229.1211.7026.980.00
Free Cash Flow-36.65-36.65-24.73-9.91-0.08
Supplemental Disclosures
Income Taxes Paid0.00-4.85-1.560.000.00